What Analyst Projections for Key Metrics Reveal About CRH (CRH) Q4 Earnings

12.02.26 15:15 Uhr

Werte in diesem Artikel
Aktien

90,58 EUR -1,18 EUR -1,29%

Indizes

609,5 PKT -2,7 PKT -0,44%

5.828,2 PKT -10,0 PKT -0,17%

6.600,7 PKT 18,0 PKT 0,27%

In its upcoming report, CRH (CRH) is predicted by Wall Street analysts to post quarterly earnings of $1.52 per share, reflecting an increase of 6.3% compared to the same period last year. Revenues are forecasted to be $9.54 billion, representing a year-over-year increase of 7.6%.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.That said, let's delve into the average estimates of some CRH metrics that Wall Street analysts commonly model and monitor.The consensus among analysts is that 'Revenue- Americas Materials Solutions' will reach $4.70 billion. The estimate points to a change of +10.1% from the year-ago quarter.Analysts expect 'Revenue- Americas Building Solutions' to come in at $1.52 billion. The estimate suggests a change of +1.7% year over year.According to the collective judgment of analysts, 'Adjusted EBITDA- Americas Materials Solutions' should come in at $1.15 billion. Compared to the present estimate, the company reported $1.05 billion in the same quarter last year.The collective assessment of analysts points to an estimated 'Adjusted EBITDA- Americas Building Solutions' of $271.01 million. The estimate is in contrast to the year-ago figure of $250.00 million. View all Key Company Metrics for CRH here>>> Shares of CRH have experienced a change of +4.9% in the past month compared to the -0.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CRH is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.See Our Newest 5 Stocks Set to Double Picks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CRH PLC (CRH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu CRH plc

Analysen zu CRH plc

DatumRatingAnalyst
06.10.2023CRH BuyJefferies & Company Inc.
27.09.2023CRH BuyJefferies & Company Inc.
26.09.2023CRH BuyUBS AG
13.09.2023CRH OverweightJP Morgan Chase & Co.
12.09.2023CRH BuyJefferies & Company Inc.
DatumRatingAnalyst
06.10.2023CRH BuyJefferies & Company Inc.
27.09.2023CRH BuyJefferies & Company Inc.
26.09.2023CRH BuyUBS AG
13.09.2023CRH OverweightJP Morgan Chase & Co.
12.09.2023CRH BuyJefferies & Company Inc.
DatumRatingAnalyst
13.07.2022CRH Equal-weightMorgan Stanley
15.03.2022CRH Equal-weightMorgan Stanley
04.03.2022CRH Equal WeightBarclays Capital
19.01.2022CRH Equal WeightBarclays Capital
17.12.2021CRH HoldKepler Cheuvreux
DatumRatingAnalyst
19.06.2023CRH SellGoldman Sachs Group Inc.
22.05.2023CRH SellGoldman Sachs Group Inc.
26.04.2023CRH SellGoldman Sachs Group Inc.
02.03.2023CRH SellGoldman Sachs Group Inc.
22.11.2022CRH SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CRH plc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen